A comparison of the leucocyte infiltration between fine needle and core  biopsy in the human renal allograft. DA Hughes, DL McWhinnie, RM Jones, NP Carter, PJ Morris. Transplant Proc 1987;19;1:1652

 

Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles. An assessment of cyclosporin, azathioprine / prednisolone and triple therapy. DL McWhinnie, NP Carter, RM Jones, RFM Wood, PJ Morris. Transplant Proc 1987;19;1:1633-1634

 

HLA-Class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts. DL McWhinnie, SV Fuggle, LS Azevedo, RM Jones, PJ Morris. Transplant Proc    1987 Oct 19 (5) 3628 - 9.

 

Evaluation of needle core biopsy washings for monitoring rejection in human renal allografts. DL McWhinnie, RM Jones, DA Hughes,  NP Carter, MS Dunnill, PJ Morris. Transpl. Proc  1988 20;4; 579 - 580

​

Site of principle metabolic defect in idiopathic haemachromatosis: insights from  transplantation of an affected organ.   P Dabkowski, P Angus, R Smallwood, J Ireton, RM Jones   BMJ 306(6894), 1726 (1993)

 

Combination antiviral therapy controls severe post -  liver transplant recurrence of Hepatitis B infection. P Angus, Richards M, Bowden S, Ireton J, Sinclair R, Jones R,  Lochinini S.  Journal of Gastr & Hepatol 1993, 8 : 353-357 

 

Donor hyaluronic acid and MEGX levels do not accurately predict post transplant liver function. Michell ID, Abdulnour I, Pzybylowski, Bowkett, Gleason A, Hardy KJ, Jones RM. Trans Proc 25(5), 2888 - 2889 (1993)

 

Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic  liver transplantation. Tancharoen S, Jones RM, Angus PW, Hardy KJ. Trans Proc 25(5), 2890 - 2891 (1993)

​

Vasoactive intestinal polypeptide and calcitonin gene related peptide levels during human liver transplantation. PL McNicol, G liu, J Hurley, KJ Hardy, RM Jones. Trans Proc 25:2. 1830 - 1831. 1993

​

Endotoxin and tumour necrosis factor levels and haemodynamics during human liver transplantation. PL McNicol, G Liu, A Shulkes, KJ Hardy, RM Jones. Trans Proc 25:2. 1828 - 1829. 1993

​

Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Angus PW, Locarnini, McGaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatology 31(1), 14 - 18 (1995)

​

Resolution of gas exchange abnormalities  and intrapulmonary pulmonary shunting following liver transplantation. Battaglia S, Irving LB, Jones RM, Angus PW.     Hepatology 25(5), 1228 - 1232 (1997)

​

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. Moaven LD, Locarnini SA, Bowden DS, Kim JP, Breschkin A, McCaw R, Yun A, Wages J Jr, Jones B, Angus P.  J Hepatol. 1997 Oct;27(4):613-9.

​

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, Chui AK, Sheil AG, Jones RM, Locarnini SA, Angus PW.   Liver Transpl Surg. 1999 Nov;5(6):512-9.

 

Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal study. Keogh JB, Tsalamandris C, Sewell RB, Jones RM, Angus PW, Nyulasi IB, Seeman E.

Nutrition. 1999 Sep;15(9):661-4.

 

Hepatocellular carcinoma and chemoembolization. Harris M, Gibbs P, Cebon J, Jones R, Sewell R, Schelleman T, Angus P. Intern Med J. 2001 Dec;31(9):517-22.

 

Liver transplant recipient selection: MELD vs. clinical judgement.  Fink MA, Angus PW, Gow PJ, Berry SR, Wang B, Muralidharan V, Christophi C, Jones RM  Liver Transplantation. 2005 11(6): 621-626.

 

A phase 1 trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.  Scott AM, Lee FT, Jones RM, Hopkins W, MacGregor DP, Cebon J, et al.   Clinical Cancer Research. 2005 11(13): 4810-4817.

 

Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.  Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, Garcia-Valdecasas JC, McAlister V, Mirza DF; rFVIIa OLT Study Group.  Liver Transpl. 2005 Aug;11(8):973-9. PubMed PMID: 16035095.

 

Risk factors for liver transplantation waiting list mortality.  Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.  J Gastroenterol Hepatol. 2007 Jan;22(1):119-24. Erratum in: J Gastroenterol
Hepatol. 2007 Mar;22(3):457. PubMed PMID: 17201891.

 

Time to review the selection criteria for transplantation in paracetamol-induced fulminant hepatic failure?  Gow PJ, Warrilow S, Lontos S, Lubel J, Wongseelashote S, MacQuillan GC, Jones RM, Bellomo R, Angus PW.

Liver Transpl. 2007 Dec;13(12):1762-3. PubMed PMID: 18044782.

​

Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand.  Chen JW, Kow L, Verran DJ, McCall JL, Munn S, Balderson GA, Fawcett JW, Gow PJ, Jones RM, Jeffrey GP, House AK, Strasser SI. HPB (Oxford). 2009 Feb;11(1):81-9. PubMed PMID: 19590628; PubMed Central PMCID: PMC2697869.

 

CMV INFECTION AND ANTIVIRAL RESISTANCE IN A LIVER TRANSPLANT COHORT FOLLOWED LONGITUDINALLY: 1945   G. M. Scott, Z. Naing, J. Pavlovic, Z. M. Waliuzzaman, J. Iwasenko, N. Rismanto, P. Angus, R. Jones, W. Rawlinson

Transplantation 01/2010; 90. · 3.78 Impact Factor .

​

Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis.   Mehrdad Nikfarjam, Vachara Niumsawatt, Arun Sethu, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert M Jones, Christopher Christophi .  HPB 08/2011; 13(8):551-8. · 1.94 Impact Factor.

 

Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients.  G M Scott, Z Naing, J Pavlovic, J M Iwasenko, P Angus, R Jones, W D Rawlinson .  Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 06/2011; 51(4):229-33. · 3.12 Impact Factor.

 

Acute hepatitis B infection following blood transfusion.   A P Rode, R M Jones, P W Angus, D Brown, P J Gow.  Internal Medicine Journal 06/2011; 41(6):509-10. · 1.82 Impact Factor.

 

Biliary stenting versus surgical bypass for palliation of periampullary malignancy.   Mehrdad Nikfarjam, Andrew K Hadj, Vijayaragavan Muralidharan, Niall Tebbutt, Michael A Fink, Robert M Jones, Graham Starkey, Rhys B Vaughan, Alexander W Marshall, Christopher Christophi.   Indian Journal of Gastroenterology 11/2012;

​

Normothermic extracorporeal perfusion of isolated porcine liver after warm ischaemia: a preliminary report.   Rinaldo Bellomo, Satoshi Suzuki, Bruno Marino, Graeme K Starkey, Brenton Chambers, Michael A Fink, Bao Zhong Wang, Shane Houston, Glenn Eastwood, Paolo Calzavacca, Neil Glassford, Alison Skene, Daryl A Jones, Robert Jones.  Critical care and resuscitation: journal of the Australasian Academy of Critical Care Medicine 09/2012; 14(3):173-6. · 1.51 Impact Factor.

​

Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C. J Howell, R Sawhney, P Angus, M Fink, R Jones, B Z Wang, K Visvanathan, P Crowley, P Gow. Transplant Infectious Disease 09/2013; · 1.98 Impact Factor.

 

Normothermic extracorporeal human liver perfusion following donation after cardiac death.   Rinaldo Bellomo, Bruno Marino, Graham Starkey, Bhao Zhong Wang, Michael A Fink, Nan Zhu, Satoshi Suzuki, Shane Houston, Glenn Eastwood, Paolo Calzavacca, [......], Brenton Chambers, Alison Skene, Antoine G Schneider, Daryl Jones, Andrew Hilton, Helen Opdam, Stephen Warrillow, Nicole Gauthier, Lynne Johnson,  Robert Jones.

 

Critical care and resuscitation: journal of the Australasian Academy of Critical Care Medicine 06/2013; 15(2):78-82. · 1.51 Impact Factor.

​

A fast track recovery program significantly reduces hospital length of stay following uncomplicated pancreaticoduodenectomy. Mehrdad Nikfarjam, Laurence Weinberg, Nicholas Low, Michael A Fink, Vijayaragavan Muralidharan, Nezor Houli, Graham Starkey, Robert Jones, Christopher Christophi.  JOP: Journal of the pancreas 01/2013; 14(1):63-70.

 

Pressurized Pulse Irrigation with Saline Reduces Surgical-site Infections following Major Hepatobiliary and Pancreatic Surgery: Randomized Controlled Trial. Mehrdad Nikfarjam, Laurence Weinberg, Michael A Fink, Vijayaragavan Muralidharan, Graham Starkey, Robert Jones, Kevin Staveley-O'Carroll, Christopher Christophi.  World Journal of Surgery 10/2013; · 2.23 Impact Factor .

 

Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: A multicenter, exploratory analysis.  M F Silva, G Sapisochin, S I Strasser, S Hewa-Geeganage, J Chen, A J Wigg, R Jones, R Saraiva, L Kikuchi, F Carrilho, P R O Fontes, R Charco.

European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 01/2013; · 2.56 Impact Factor

 

A novel biomarker of immune function and initial experience in a transplant population.  Siddharth Sood, Diana Cundall, Lijia Yu, Misato Miyamasu, Jefferey S Boyle, Sim Y Ong, Paul J Gow, Robert M Jones, Peter W Angus, Kumar Visvanathan, Adam G Testro.  Transplantation 04/2014; 97(8):e50-1. · 3.78 Impact Factor.

​

Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.

M M Page, E I Ekinci, R M Jones, P W Angus, P J Gow, R C O'Brien.  Internal Medicine Journal 06/2014; 44(6):601-4. · 1.70 Impact Factor.